One Ascent Financial Services LLC Galapagos Nv Transaction History

One Ascent Financial Services LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$52.17 - $70.2 $142,058 - $191,154	-2,723 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$76.15 - $111.94 $456 - $671	6 Added 0.22%	2,723 $210,000
Q4 2020 Jan 13, 2021	BUY	$96.85 - $148.25 $66,535 - $101,847	687 Added 33.84%	2,717 $269,000
Q3 2020 Nov 02, 2020	BUY	$122.47 - $213.56 $86,831 - $151,414	709 Added 53.67%	2,030 $288,000
Q2 2020 Jul 21, 2020	BUY	$185.52 - $231.25 $6,493 - $8,093	35 Added 2.72%	1,321 $261,000
Q1 2020 Apr 14, 2020	SELL	$143.0 - $274.03 $22,165 - $42,474	-155 Reduced 10.76%	1,286 $252,000
Q4 2019 Feb 11, 2020	BUY	$146.12 - $215.82 $210,558 - $310,996	1,441 New	1,441 $298,000
Q3 2019 Nov 15, 2019	SELL	$130.44 - $187.64 $345,796 - $497,433	-2,651 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$111.45 - $128.93 $295,453 - $341,793	2,651 New	2,651 $342,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.58B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of One Ascent Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on One Ascent Financial Services LLC with notifications on news.